Targeting of pyrroline-5-carboxylate reductase (PYCR) reduces drug resistance in multiple myeloma in vitro.
- Oudaert, I. (Speaker)
- Menu, E. (Contributor)
- De Veirman, K. (Contributor)
Activity: Talk or presentation › Talk or presentation at a conference